![Naseem Zojwalla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Naseem Zojwalla
Hoofd Techniek/Wetenschap/O&O bij
OLEMA PHARMACEUTICALS, INC.
Vermogen: 51 388 $ op 31-07-2026
Profiel
Naseem Zojwalla currently works at Olema Pharmaceuticals, Inc., as Chief Medical Officer from 2022.
Dr. Zojwalla also formerly worked at Peloton Therapeutics, Inc., as Vice President-Clinical Development from 2015 to 2020, Turning Point Therapeutics, Inc., as Vice President-Clinical Development from 2020 to 2022, and Columbia University Irving Medical Center, as Assistant Clinical Professor-Medicine.
Dr. Zojwalla received her undergraduate degree from Stanford University and doctorate degree from Temple University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-02-2026 | 4.488 ( 0,01% ) | 51 388 $ | 31-07-2026 |
Actieve functies van Naseem Zojwalla
| Bedrijven | Functie | Begin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-01-2022 |
Eerdere bekende functies van Naseem Zojwalla
| Bedrijven | Functie | Einde |
|---|---|---|
| TURG POIN | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
| PELOTON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Naseem Zojwalla
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
